These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6663768)

  • 1. [Differential examination of the serous fluid and key points in clinical tests].
    Takayanagi N
    Rinsho Byori; 1983 Sep; 31(9):927-33. PubMed ID: 6663768
    [No Abstract]   [Full Text] [Related]  

  • 2. [Deviations in glycoprotein contents in malignant ascitic fluid and pleural effusions].
    Ohtani H
    Rinsho Byori; 1983 Sep; 31(9):940-4. PubMed ID: 6663770
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnostic efficacy of estimating fibrinogen/fibrin degradation products in pleural and peritoneal effusion fluids.
    Dube B; Narayanan R; Dube RK; Singh VP
    J Assoc Physicians India; 1984 Jun; 32(6):493-5. PubMed ID: 6511725
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical examination of the body cavity fluids].
    Seki T
    Rinsho Byori; 1983 Sep; 31(9):934-9. PubMed ID: 6663769
    [No Abstract]   [Full Text] [Related]  

  • 5. [Contribution to the cytology of serous effusions. (Examination of 838 fluids)].
    Franchi F; Nava C; Cavazzuti F
    Omnia Med Ther; 1967; 45(2):275-97. PubMed ID: 5613942
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diagnostic criteria for the tumor markers of the body fluids].
    Konishi K; Nakagawa S; Watanabe K; Takamura S
    Rinsho Byori; 1983 Sep; 31(9):945-54. PubMed ID: 6198536
    [No Abstract]   [Full Text] [Related]  

  • 7. [Significance of ferritin determination in pleural effusions and ascitic fluid].
    Yu SY
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1985 Feb; 8(1):28-30, 61. PubMed ID: 3996130
    [No Abstract]   [Full Text] [Related]  

  • 8. [Concentrations of carcinoembryonic antigen and ferritin in pleural and ascitic effusion of various origins].
    Stabellini G; Trevisani L; Sartori S; Pazzi P
    Gastroenterol Clin Biol; 1985; 9(6-7):543-5. PubMed ID: 4018490
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative study of serous effusion using three methods of investigation: conventional cytology, tetracycline test, and millipore filters].
    Pieron R; Kauffmann JP; Jagueux M
    Poumon Coeur; 1973 Feb; 29(2):111-2 passim. PubMed ID: 4777812
    [No Abstract]   [Full Text] [Related]  

  • 10. [Recognition of tumorous and non-tumorous cells in cytological studies of serous fluids].
    Kurbatova TI
    Vopr Onkol; 1968; 14(11):29-36. PubMed ID: 5729483
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical value of determining fibrin and fibrinogen degradation products in kidney diseases].
    Belitskaia GA; Ena IaM; Varetskaia TV; Shevchenko LI
    Klin Med (Mosk); 1976 Mar; 54(3):96-102. PubMed ID: 966670
    [No Abstract]   [Full Text] [Related]  

  • 12. [Detection of D -dimer in pleural effusion].
    Lü YD; Chen P; Xu M
    Hunan Yi Ke Da Xue Xue Bao; 2000 Feb; 25(1):71-2. PubMed ID: 12212257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships among tumor burden, tumor size, and the changing concentrations of fibrin degradation products and fibrinolytic factors in the pleural effusions of rabbits with VX2 lung tumors.
    Hatton MW; Southward SM; Ross BL; Clarke BJ; Singh G; Richardson M
    J Lab Clin Med; 2006 Jan; 147(1):27-35. PubMed ID: 16443002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility of body fluid analyses.
    Cheson BD
    Clin Lab Med; 1985 Jun; 5(2):195-208. PubMed ID: 3896622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of ascitic fluid FDP and fibrinolytic activity assay].
    Lu XG; Chen CS; Ye ZY
    Zhonghua Nei Ke Za Zhi; 1987 Sep; 26(9):530-2, 565. PubMed ID: 3450474
    [No Abstract]   [Full Text] [Related]  

  • 16. [Identification of fibrinogen or fibrin degradation products in the ascitic fluid].
    Kolodie L; Detante J; Rachail M
    Nouv Presse Med; 1978 Feb; 7(8):665. PubMed ID: 417295
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of immunoperoxidase staining in serous effusions.
    Sarker AB; Hoshida Y; Nose S
    Bangladesh Med Res Counc Bull; 1993 Aug; 19(2):33-8. PubMed ID: 8161332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of the quantitative determination of "fibrin degradation products" in renal diseases.
    Chin Med J (Engl); 1980 Jul; 93(7):483-6. PubMed ID: 6772396
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical application of electrophoresis. 3. Analysis of ascitic and pleural fluid proteins].
    Takayanagi N
    Rinsho Byori; 1973 Mar; 21(3):214-6. PubMed ID: 4738652
    [No Abstract]   [Full Text] [Related]  

  • 20. [Selection of bedside tests. General tests--examination of the urine, feces, pleural effusion, and ascitic fluid].
    Hokama S
    Rinsho Byori; 1987 Jul; Spec No 72():11-9. PubMed ID: 3509251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.